licensing – Duane Morris Life Sciences Law

Duane Morris’ Life Sciences and Medical Technologies Industry Group has been ranked in The Legal 500 US 2021 guide.

An excerpt from the publication:

Duane Morris LLP is recommended for its expertise in M&A, patents, and commercial licensing and collaboration agreements, acting for domestic companies in addition to a strong roster of clients in the Asia-Pacific region.

Testimonials

- - - “They understand client’s needs and work very closely to address those. Team has subject knowledge and applies it effectively in strategizing pre-litigation and litigation matters.”
    - “They suggest different strategies and ideas for defenses. Also, innovative ways for settlement terms. Billing is also great and adjusts according to client’s needs.”
    - “Rick Ball is the individual who stands out. He gels with client’s team very well, understands their needs, flexible, innovative, strategizes properly.”

For more information, please visit the firm website.

By Jennifer A. Kearns, John M. Neclerio and Vicki G. Norton

Who doesn’t like the favorite sandwich of childhood – peanut butter and jelly? The two substances blend and meld together, creating a delectable gooey, messy, sticky and sweet treat.

In the life sciences, commingled intellectual property can also create “gooey,” messy and sticky problems for companies. Unfortunately, there’s nothing sweet about commingled IP and the complications that can arise from it, and you can be sure that an experience arising from claims of commingled IP will leave a sour taste in your mouth. Here we discuss proactive or preventative steps that companies can take to reduce the risk of commingling IP.

Continue reading “COMMINGLED INTELLECTUAL PROPERTY–LIKE PEANUT BUTTER AND JELLY?”